ICD Latest Quarter's Earnings
| Announce Date | 08/07/2024 |
| EPS Normalized Actual | $-0.73 (Beat by $0.03) |
| EPS GAAP Actual | $-0.73 (Beat by $0.03) |
| Revenue Actual | $0.037992B |
| Revenue Surprise | Beat by $37.992M |
Upcoming Quarter's Earnings
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | 0.05 | 11.72 | 0.05 | 0.05 | 1 |
| Dec 2024 | -0.55 | -1.07 | -0.93 | -0.06 | 3 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | -1.27 | -0.64 | 0.037992B | -16.25% | -3.86M |
| FQ2 2024 (Jun 2024) | -1.15 | -2.49259 | 0.043327B | -30.07% | -33.96M |
| FQ1 2024 (Mar 2024) | -0.62 | -0.16 | 0.046636B | -36.71% | -22.19M |
| FQ4 2023 (Dec 2023) | -1.84 | -1.45817 | 0.04583B | -31.48% | 0.83M |
| FQ3 2023 (Sep 2023) | -0.54 | -0.54 | 0.044164B | -11.28% | 44.16M |
| FQ3 2001 (Sep 2001) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2023 (Jun 2023) | -0.3 | -0.3 | 0.056356B | 24.92% | 56.36M |
| FQ1 2023 (Mar 2023) | 0.0009 | 0.0009 | 0.063756B | 100% | 63.76M |
Quarterly Estimates Summary
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
3
Revenue # of in-lines
1
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | -0.63 | -1.27 | -0.64 | 50.39% |
| FQ2 2024 (Jun 2024) | 1.34259 | -1.15 | -2.49259 | 216.75% |
| FQ1 2024 (Mar 2024) | -0.46 | -0.62 | -0.16 | 25.81% |
| FQ4 2023 (Dec 2023) | -0.38183 | -1.84 | -1.45817 | 79.25% |
| FQ3 2023 (Sep 2023) | -0.54 | -0.54 | 100% | |
| FQ3 2001 (Sep 2001) | 0 | 0 | NAN% | |
| FQ2 2023 (Jun 2023) | -0.3 | -0.3 | 100% | |
| FQ1 2023 (Mar 2023) | 0.0009 | 0.0009 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | $0.04B | $0.04B | $-3.86M | -10.16% |
| FQ2 2024 (Jun 2024) | $0.08B | $0.04B | $-33.96M | -78.38% |
| FQ1 2024 (Mar 2024) | $0.07B | $0.05B | $-22.19M | -47.58% |
| FQ4 2023 (Dec 2023) | $0.05B | $0.05B | $0.83M | 1.8% |
| FQ3 2023 (Sep 2023) | $0B | $0.04B | $44.16M | 100% |
| FQ3 2001 (Sep 2001) | $0B | $0B | $0M | NAN% |
| FQ2 2023 (Jun 2023) | $0B | $0.06B | $56.36M | 100% |
| FQ1 2023 (Mar 2023) | $0B | $0.06B | $63.76M | 100% |
ICD Ratings Summary
ICD Quant Ranking
